Mark Waltham

7.2k total citations · 2 hit papers
72 papers, 5.4k citations indexed

About

Mark Waltham is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mark Waltham has authored 72 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 27 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Mark Waltham's work include Cancer Cells and Metastasis (16 papers), Biochemical and Molecular Research (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Mark Waltham is often cited by papers focused on Cancer Cells and Metastasis (16 papers), Biochemical and Molecular Research (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Mark Waltham collaborates with scholars based in Australia, United States and United Kingdom. Mark Waltham's co-authors include John N. Weinstein, Uwe Scherf, Timothy G. Myers, Michael B. Eisen, Patrick O. Brown, David Botstein, Douglas T. Ross, Erik W. Thompson, Jae K. Lee and Dari Shalon and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Mark Waltham

68 papers receiving 5.2k citations

Hit Papers

Systematic variation in gene expression patterns in human... 2000 2026 2008 2017 2000 2000 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Systematic variation in gene expression patterns in human cancer cell lines
    2000 1.6k citations Douglas T. Ross, Uwe Scherf et al. Nature Genetics profile →
  2. A gene expression database for the molecular pharmacology of cancer
    2000 1.1k citations Uwe Scherf, Douglas T. Ross et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Waltham Australia 29 3.9k 1.3k 858 436 399 72 5.4k
Nadine K. Kolas United States 15 5.1k 1.3× 813 0.6× 596 0.7× 648 1.5× 570 1.4× 18 5.8k
Uwe Scherf United States 22 3.7k 1.0× 801 0.6× 647 0.8× 374 0.9× 201 0.5× 32 4.9k
Kwong‐Kwok Wong United States 48 4.0k 1.0× 1.4k 1.1× 1.7k 1.9× 531 1.2× 390 1.0× 131 6.7k
Anna Asplund Sweden 32 3.7k 0.9× 723 0.6× 983 1.1× 441 1.0× 346 0.9× 71 5.3k
Marketa Zvelebil United Kingdom 49 5.8k 1.5× 1.6k 1.2× 863 1.0× 670 1.5× 1.2k 2.9× 102 8.2k
Graham Ball United Kingdom 42 3.3k 0.9× 1.8k 1.4× 2.0k 2.3× 573 1.3× 333 0.8× 172 6.4k
Sampsa Hautaniemi Finland 49 4.9k 1.3× 1.5k 1.2× 1.6k 1.8× 1.1k 2.4× 510 1.3× 186 7.6k
Deval Lashkari United States 14 4.6k 1.2× 824 0.6× 766 0.9× 705 1.6× 360 0.9× 19 5.9k
Jane Staunton United States 12 3.9k 1.0× 843 0.7× 676 0.8× 284 0.7× 416 1.0× 16 6.0k
Kevin R. Brown Canada 25 3.7k 0.9× 660 0.5× 565 0.7× 377 0.9× 447 1.1× 59 4.5k

Countries citing papers authored by Mark Waltham

Since Specialization
Citations

This map shows the geographic impact of Mark Waltham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Waltham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Waltham more than expected).

Fields of papers citing papers by Mark Waltham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Waltham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Waltham. The network helps show where Mark Waltham may publish in the future.

Co-authorship network of co-authors of Mark Waltham

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Waltham. A scholar is included among the top collaborators of Mark Waltham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Waltham. Mark Waltham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Waltham, Mark, Galina Polekhina, Daniella Brasacchio, et al.. (2025). Dynamic Profiling of Cell Free Tumour DNA in Aggressive B‐Cell Lymphoma From Diagnosis to Transformation at Relapse. eJHaem. 6(4). e70126–e70126. 1 indexed citations
2.
Fettke, Heidi, Edmond M. Kwan, Andrew Mant, et al.. (2018). Plasma Cell-Free DNA (cfDNA) Concentration and Outcomes in Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Patients Treated with Androgen Receptor Signalling Inhibitors (ARSIs). Asia-Pacific Journal of Clinical Oncology. 14. 29–29. 1 indexed citations
3.
Fifis, Theodora, Linh T. Nguyen, Cathy Malcontenti‐Wilson, et al.. (2013). Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor. QUT ePrints (Queensland University of Technology). 1 indexed citations
4.
5.
Blick, Tony, Honor J. Hugo, Edwin Widodo, et al.. (2010). Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast Cancer. Journal of Mammary Gland Biology and Neoplasia. 15(2). 235–252. 15 indexed citations
6.
Qi, Weier, Xinming Chen, Richard E. Gilbert, et al.. (2007). High Glucose-Induced Thioredoxin-Interacting Protein in Renal Proximal Tubule Cells Is Independent of Transforming Growth Factor-β1. American Journal Of Pathology. 171(3). 744–754. 67 indexed citations
7.
McLennan, Susan V., Darren J. Kelly, Maria Schäche, et al.. (2007). Advanced glycation end products decrease mesangial cell MMP-7: A role in matrix accumulation in diabetic nephropathy?. Kidney International. 72(4). 481–488. 45 indexed citations
8.
Newgreen, Donald F., et al.. (2006). MYOEPITHELIAL MOLECULAR MARKERS IN HUMAN BREAST CARCINOMA PMC42-LA CELLS ARE INDUCED BY EXTRACELLULAR MATRIX AND STROMAL CELLS. In Vitro Cellular & Developmental Biology - Animal. 42(10). 298–307. 7 indexed citations
9.
Price, John T., J Quinn, Natalie A. Sims, et al.. (2005). The HSP90 pharmacological inhibitor, 17-AAG, enhances breast-bone metastasis in a nude mouse model and stimulates in vitro and in vivo osteoclast formation. Cancer Treatment Reviews. 31. 1 indexed citations
10.
Lafleur, Marc A., Angela F. Drew, Tony Blick, et al.. (2004). Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: A major induction of stromal MMP‐13. International Journal of Cancer. 114(4). 544–554. 57 indexed citations
11.
Rae, James M., Susan J. Ramus, Mark Waltham, et al.. (2004). Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties. Queensland's institutional digital repository (The University of Queensland). 6 indexed citations
12.
Sharp, Julie A., Mark Waltham, Elizabeth D. Williams, Michael A. Henderson, & Erik W. Thompson. (2004). Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice. Clinical & Experimental Metastasis. 21(1). 19–29. 34 indexed citations
13.
Ackland, M. Leigh, et al.. (2003). Epidermal Growth Factor-Induced Epithelio-Mesenchymal Transition in Human Breast Carcinoma Cells. Laboratory Investigation. 83(3). 435–448. 7 indexed citations
14.
Weinstein, John N., Uwe Scherf, Douglas T. Ross, et al.. (1999). A cDNA microarray gene expression database for cancer drug discovery. Nature Genetics. 23(S3). 81–81. 4 indexed citations
15.
Li, Guang, Mark Waltham, N L Anderson, et al.. (1997). Rapid mass spectrometric identification of proteins from two‐dimensional polyacrylamide gels after in gel proteolytic digestion. Electrophoresis. 18(3-4). 391–402. 73 indexed citations
16.
Görlick, Richard, Erdem Göker, Tanya Trippett, et al.. (1996). Intrinsic and Acquired Resistance to Methotrexate in Acute Leukemia. New England Journal of Medicine. 335(14). 1041–1048. 201 indexed citations
17.
18.
19.
Waltham, Mark, et al.. (1993). Effect of Codon 22 Mutations on Substrate and Inhibitor Binding for Human Dihydrofolate Reductase. Advances in experimental medicine and biology. 338. 515–519. 3 indexed citations
20.
Waltham, Mark, et al.. (1989). Interactions with hemoglobin: A source of error in measurements of transketolase activity in hemolysates. Clinica Chimica Acta. 180(3). 265–275. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadine K. Kolas Breakdown of academic impact, for papers by Uwe Scherf Breakdown of academic impact, for papers by Kwong‐Kwok Wong Breakdown of academic impact, for papers by Anna Asplund Breakdown of academic impact, for papers by Marketa Zvelebil Breakdown of academic impact, for papers by Graham Ball Breakdown of academic impact, for papers by Sampsa Hautaniemi Breakdown of academic impact, for papers by Deval Lashkari Breakdown of academic impact, for papers by Jane Staunton Breakdown of academic impact, for papers by Kevin R. Brown
Rankless by CCL
2026